For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Ionis Pharmaceuticals Inc (NASDAQ: IONS) closed at $43.78 in the last session, up 2.17% from day before closing price of $42.85. In other words, the price has increased by $2.17 from its previous closing price. On the day, 1.6 million shares were traded. IONS stock price reached its highest trading level at $43.82 during the session, while it also had its lowest trading level at $42.8.
Ratios:
We take a closer look at IONS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 3.13 whereas as Long-Term Debt/Eq ratio is at 2.11.
On July 01, 2025, Barclays Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $57.
On April 07, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $45.H.C. Wainwright initiated its Buy rating on April 07, 2025, with a $45 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 06 ’25 when PARSHALL B LYNNE sold 5,000 shares for $41.93 per share. The transaction valued at 209,646 led to the insider holds 86,344 shares of the business.
Geary Richard S sold 10,000 shares of IONS for $428,593 on Aug 05 ’25. The EVP, Chief Development Officer now owns 89,492 shares after completing the transaction at $42.86 per share. On Aug 06 ’25, another insider, PARSHALL B LYNNE, who serves as the Officer of the company, bought 10,000 shares for $41.93 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IONS now has a Market Capitalization of 6978138112 and an Enterprise Value of 6669180928. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.39 while its Price-to-Book (P/B) ratio in mrq is 11.03. Its current Enterprise Value per Revenue stands at 7.064 whereas that against EBITDA is -26.136.
Stock Price History:
The Beta on a monthly basis for IONS is 0.28, which has changed by -0.08102435 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, IONS has reached a high of $50.43, while it has fallen to a 52-week low of $23.95. The 50-Day Moving Average of the stock is 8.06%, while the 200-Day Moving Average is calculated to be 24.27%.
Shares Statistics:
According to the various share statistics, IONS traded on average about 1.85M shares per day over the past 3-months and 2157450 shares per day over the past 10 days. A total of 159.20M shares are outstanding, with a floating share count of 155.53M. Insiders hold about 2.42% of the company’s shares, while institutions hold 106.67% stake in the company. Shares short for IONS as of 1753920000 were 11580340 with a Short Ratio of 6.27, compared to 1751241600 on 14139627. Therefore, it implies a Short% of Shares Outstanding of 11580340 and a Short% of Float of 9.64.
